Lantus – said to be the most administered basal insulin across the world – continues to make blockbuster sales, bringing in almost $775 million for Sanofi in the first quarter of this year.

In Q3, sales of Lantus were down 9.8% compared with the same period last year, at just under $1.4 billion. Sanofi announced this week plans to cut 20% of jobs in its US diabetes and cardiovascular ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

The insulin plant is one example of a natural option for controlling blood sugar levels. Few but encouraging small-scale research points to Costus ignis's possible benefits.

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Apple quietly makes running Linux containers easier on Macs At WWDC, Apple announced it was taking a significant step to improve Linux container support on Macs.

Home News Business Stocks Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins ...

Image: JinkoSolar. The leading crystalline silicon solar manufacturers have shipped a record 500GW of PV modules in 2024, according to a report from analysts Wood Mackenzie.

In addition, no data are available on the effects of insulin control on preventing dementia in CKD patients with diabetes and hypertension.” Data derived from Chen YY, et al. BMC Nephrol. 2025 ...

Law Unanimous Supreme Court makes it easier to sue schools in disability cases June 12, 202510:37 AM ET Heard on All Things Considered Nina Totenberg ...